BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 2996708)

  • 1. Maitotoxin activates quantal transmitter release at the neuromuscular junction: evidence for elevated intraterminal Ca2+ in the motor nerve terminal.
    Kim YI; Login IS; Yasumoto T
    Brain Res; 1985 Nov; 346(2):357-62. PubMed ID: 2996708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of alteration of nerve terminal Ca2+ regulation on increased spontaneous quantal release of acetylcholine by methyl mercury.
    Levesque PC; Atchison WD
    Toxicol Appl Pharmacol; 1988 Jun; 94(1):55-65. PubMed ID: 3376114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new type of transmitter release at the neuromuscular junction.
    Thesleff S; Molgó J
    Neuroscience; 1983 May; 9(1):1-8. PubMed ID: 6308500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of action of lead on neuromuscular junctions.
    Atchison WD; Narahashi T
    Neurotoxicology; 1984; 5(3):267-82. PubMed ID: 6097847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of maitotoxin on the transmission of neuromuscular junction in rats].
    Li LJ; Liu CG
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2001 May; 17(2):133-6. PubMed ID: 21171399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylmercury-induced depression of neuromuscular transmission in the rat.
    Atchison WD; Narahashi T
    Neurotoxicology; 1982 Nov; 3(3):37-50. PubMed ID: 6298679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The thiol-oxidizing agent diamide increases transmitter release by decreasing calcium requirements for neuromuscular transmission in the frog.
    Carlen PL; Kosower EM; Werman R
    Brain Res; 1976 Nov; 117(2):257-76. PubMed ID: 186154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium-dependent increase in quantal secretion induced by brevetoxin-3 in Ca2+-free medium is associated with depletion of synaptic vesicles and swelling of motor nerve terminals in situ.
    Meunier FA; Colasante C; Molgo J
    Neuroscience; 1997 Jun; 78(3):883-93. PubMed ID: 9153666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes of quantal transmitter release caused by gadolinium ions at the frog neuromuscular junction.
    Molgó J; del Pozo E; Baños JE; Angaut-Petit D
    Br J Pharmacol; 1991 Sep; 104(1):133-8. PubMed ID: 1686201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of lead on neuromuscular transmission in the frog.
    Manalis RS; Cooper GP; Pomeroy SL
    Brain Res; 1984 Feb; 294(1):95-109. PubMed ID: 6320979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In botulinum type A-poisoned frog motor endings ouabain induces phasic transmitter release through Na+-Ca2+ exchange.
    Molgo J; Angaut-Petit D; Thesleff S
    Brain Res; 1987 May; 410(2):385-9. PubMed ID: 3036311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the role of barium in supporting the asynchronous release of acetylcholine quanta by motor nerve impulses.
    Silinsky EM
    J Physiol; 1978 Jan; 274():157-71. PubMed ID: 304889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of prednisolone on neuromuscular transmission in the rat diaphragm.
    Van Wilgenburg H
    Eur J Pharmacol; 1979 May; 55(4):355-61. PubMed ID: 223852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement by Anemonia sulcata toxin II of spontaneous quantal transmitter release from mammalian motor nerve terminals.
    Molgo J; Lemeignan M; Tazieff-Depierre F
    Toxicon; 1986; 24(5):441-50. PubMed ID: 2872736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of synchronization of quantal transmitter release from mammalian motor endings by the use of botulinal toxins type A and D.
    Molgó J; Siegel LS; Tabti N; Thesleff S
    J Physiol; 1989 Apr; 411():195-205. PubMed ID: 2575665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presynaptic effects of bekanamycin at the frog neuromuscular junction. Reversibility by calcium and aminopyridines.
    Uchiyama T; Molgo J; Lemeignan M
    Eur J Pharmacol; 1981 Jul; 72(4):271-80. PubMed ID: 6268416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous transmitter release in experimental neuromuscular disorders of the rat.
    Thesleff SW
    Muscle Nerve; 1982; 5(9S):S12-6. PubMed ID: 6302487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase in transmitter release from motor nerve terminals induced by some pyridine derivatives.
    Montoya GA; Molgó J; Lemeignan M; Lechat P
    Acta Physiol Pharmacol Latinoam; 1984; 34(4):409-18. PubMed ID: 6242265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium-independent increase of transmitter release at frog end-plate by trinitrobenzene sulphonic acid.
    Kijima H; Tanabe N
    J Physiol; 1988 Sep; 403():135-49. PubMed ID: 3150982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition by neosurugatoxin and omega-conotoxin of acetylcholine release and muscle and neuronal nicotinic receptors in mouse neuromuscular junction.
    Hong SJ; Tsuji K; Chang CC
    Neuroscience; 1992; 48(3):727-35. PubMed ID: 1318519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.